Live Breaking News & Updates on Cervical Intraepithelial

Stay updated with breaking news from Cervical intraepithelial. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

BD Partners with Camtech Health to Increase Access to Cervical Cancer Screening in Singapore

First-Ever Program in the Country to Offer At-Home Self-Collection of Samples for HPV Testing
SINGAPORE, Feb. 21, 2024 /PRNewswire/ BD , a leading global medical technology company, today. ....

United States , South Korea , Troy Kirkpatrick , Keefe Chee , Intraepithelial Neoplasia , Jeff Andrews , Kuok Meng , Hologic Preservcyt , Adam Reiffe , Ida Ismail Pratt , Clin Microbiol , Health Promotion Board , Life Sciences , Research Surveillance Group , National Population Health , Global Medical Affairs , Ministry Of Health , Camtech Health , World Health Organization , Advisor Of The Alliance For Active Action , Camtech Health App , Epidemiology Disease Control Division , Intj Environ Res Public Health , First Ever Program , Offer At Home Self Collection , Global Strategy ,

Cervical Intraepithelial Neoplasia Pipeline Research Report 2023 Featuring Inovio Pharmaceuticals, Frantz Viral Therapeutics, Antiva Biosciences, Genexine, and Merck Sharp & Dohme

/PRNewswire/ The "Cervical Intraepithelial Neoplasia - Pipeline Insight, 2023" clinical trials has been added to ResearchAndMarkets.com s offering. The. ....

Laura Wood , Intravaginal Artesunate , Antiva Biosciences , Intraepithelial Neoplasia , Genexine Inc , E St Office Hours Call , Pipeline Development Activities , Office Hours Call , Society Of Gynecologic Oncology , Inovio Pharmaceuticals , Cervical Intraepithelial Neoplasia , Cervical Intraepithelial , Intraepithelial Neoplasia Emerging Drugs Chapters , Frantz Viral , Gynecologic Oncology , First In Human Proof Of Concept Trial , Pipeline Development , Free Call , Hours Call , Research And Markets ,

BD Announces Industry-First CE Marked Assay for HPV Screening from At-Home Self-Collected Vaginal Samples

Share this article
Share this article
FRANKLIN LAKES, N.J., May 13, 2021 /PRNewswire/ BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the industry s first self-collection claim for HPV screening has been CE marked to the IVD directive 98/79/EC.
The new claim allows laboratories and facilities to process self-collected samples via a BD diluent tube using the BD Onclarity™ HPV Assay on either the BD Viper™ LT or the BD COR™ System. The BD Viper™ LT is in use globally and the BD COR™ System, launched last year, is in use across Europe.
BD Onclarity™ HPV Assay 3-Well PCR Reagent Wells ....

United States , Hologic Preservcyt , Jeff Andrews , Jesper Bonde , Intraepithelial Neoplasia , Troy Kirkpatrick , Clin Microbiol , Kristenm Stewart , Global Medical Affairs , European Union , World Health Organization , European Union Member States , Molecular Pathology Laboratory , Global Strategy , Cervical Cancer , Senior Researcher , Molecular Pathology Laboratory Manager , Hvidovre Hospital , Brooke Story , Integrated Diagnostic Solutions , Collection Vial , Cervical Brush Diluent , Public Relations , Epidemiol Biomarkers Prev Published Online First , Test Accuracy , Human Papillomavirus ,